Metronomic docetaxel chemotherapy in combination with AEE788, (a combined EGFR and VEGFR inhibitor), has shown encouraging activity in an orthotopic mouse model of ovarian cancer utilising a cell line resistant to conventional chemotherapy dosing [38]. Here, KDR is linked to ovarian carcinoma.